Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from OncoSil Medical Ltd ( (AU:OSL) ).
The Australian Securities Exchange has suspended quotation of a specific class of OncoSil Medical Ltd securities, identified by the code OSLOE, under Listing Rule 17.3.4 pending the company’s compliance with Listing Rule 2.5. The suspension affects only this particular class of securities and does not impact any of OncoSil Medical’s other quoted securities, limiting the immediate effect to holders of the OSLOE class.
ASX Compliance issued the suspension notice, signalling regulatory concerns focused on listing rule compliance for this security class rather than the company’s overall listing status. Investors in other OncoSil securities remain unaffected in terms of trading status, though the action may prompt closer scrutiny of the company’s adherence to ASX requirements.
The most recent analyst rating on (AU:OSL) stock is a Hold with a A$0.61 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd is a listed medical company whose securities trade on the Australian Securities Exchange, offering different classes of quoted securities to investors.
Average Trading Volume: 60,050
Technical Sentiment Signal: Sell
Current Market Cap: A$14.58M
See more insights into OSL stock on TipRanks’ Stock Analysis page.